Skelaxin Pay-For-Delay Battle Heads To Pa. State Court
By Matt Fair ( November 7, 2012, 4:03 PM EST) -- The latest front in the ongoing antitrust dispute over the muscle relaxant Skelaxin opened in Pennsylvania state court Monday as the head of SigmaPharm Inc. accused a Pfizer unit of conspiring with a Mutual Pharmaceutical Co. Inc. executive to keep generic forms of the drug off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.